Financial Results - BIO-key International, Inc. reported its financial results for the year ending 2025 on March 3, 2026[5]. - The company’s cash position at year-end 2025 was highlighted in the press release[5]. - Specific financial metrics and performance indicators were not detailed in the provided content[5]. - The press release is attached as Exhibit 99, which may contain further financial details[7]. - The report was signed by Cecilia C. Welch, Chief Financial Officer, indicating official acknowledgment of the financial results[11]. Legal and Regulatory - The filing is not considered "filed" under the Securities Exchange Act, which may affect its legal implications[6]. - The company has not indicated whether it is an emerging growth company in this report[4]. Company Information - The company is registered under the Nasdaq Capital Market with the trading symbol BKYI[3]. - No information regarding user data, future outlook, or new product developments was provided in the content[5]. - There are no details on market expansion or mergers and acquisitions in the provided content[5].
BIO-key(BKYI) - 2025 Q4 - Annual Results